COPD Patients' journey: can a new inhaler ease breathing and improve life?
NCT ID NCT06511193
Summary
This study follows 152 adults with COPD in Canada for six months after their doctor prescribes a specific triple-combination inhaler (BGF/Breztri). The goal is to see how this treatment affects their breathing symptoms, quality of life, and flare-ups in a real-world setting. Researchers will track changes through patient questionnaires and medical records.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Windsor, Ontario, N8W 5V7, Canada
Conditions
Explore the condition pages connected to this study.